The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Patents, Royalties, Other Intellectual Property - GenomeDx
Travel, Accommodations, Expenses - GenomeDx
Addition of carboplatin to chemotherapy regimens for metastatic castrate-resistant prostate cancer in post-second generation hormone therapy setting: Does it improve treatment response and survival outcomes?
 
Jamal Alamiri
No Relationships to Disclose
 
Mohamed E. Ahmed
No Relationships to Disclose
 
Jack R. Andrews
No Relationships to Disclose
 
Manaf Alom
No Relationships to Disclose
 
Giovanni Motterle
No Relationships to Disclose
 
Julianna Higa
No Relationships to Disclose
 
Jeffrey Karnes
No Relationships to Disclose
 
Eugene D. Kwon
No Relationships to Disclose
 
Alan Haruo Bryce
Honoraria - Astellas Pharma
Travel, Accommodations, Expenses - Clovis Oncology (Inst); Phosplatin Therapeutics (Inst)